Recursion Pharmaceuticals Inc (RXRX) — Defensive Interval Ratio
Recursion Pharmaceuticals Inc (RXRX) has a Defensive Interval Ratio of 44 days as of June 2026. Defensive assets of $14.39 Million (cash $-, short-term investments $-, receivables $14.39 Million) cover 44 days of daily cash needs of $328.45K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Recursion Pharmaceuticals Inc Defensive Interval Ratio (2019–2025)
This chart shows how Recursion Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 44 days, meaning defensive assets of $14.39 Million can fund 44 days of operations without new revenue. For the complete balance sheet picture, see Recursion Pharmaceuticals Inc balance sheet assets.
Annual Defensive Interval Ratio for Recursion Pharmaceuticals Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Recursion Pharmaceuticals Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See how liquid is Recursion Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 61 days | $24.65 Million | $404.68K/day | $- | $- | ▼ -35 days |
| 2024 | 96 days | $49.17 Million | $513.62K/day | $- | $- | ▲ +84 days |
| 2023 | 12 days | $3.09 Million | $255.26K/day | $- | $- | ▲ +2 days |
| 2022 | 10 days | $2.75 Million | $274.70K/day | $- | $0.00 | ▼ -1872 days |
| 2021 | 1882 days | $240.54 Million | $127.83K/day | $- | $231.45 Million | ▲ +1879 days |
| 2020 | 2 days | $156.00K | $63.28K/day | $- | $0.00 | ▼ -6 days |
| 2019 | 8 days | $151.00K | $18.31K/day | $- | $- | — |